You know the Tale of Two Cities. This article, however, tells the Tale of Two Books: Bad Pharma, a 430-page book by Ben Goldacre, a British physician, whose previous book, Bad Science, was a best seller in the non-fiction realm and the much smaller 123-page book Devalued and Distrusted by John L. LaMattina, former president of research and develop at Pfizer.
Part Novo's diabetes marketing strategy involves celebrities who usually do not register with 'hoity-toity' upper-income white folk. These include NASCAR racecar driver Charlie Kimball, southern belle celebrity chef Paula Deen, and recently ordained Pentecostal minister Joseph Ward Simmons, aka Rev. Run of the hip-hop group Run-D.M.C. 'Redeemed sinner' seems to be a pattern among Novo Nordisk's celebrity spokespeople.
Welcome to Volume 12, Issue #7 (9 September 2013) of Pharma Marketing News.
Welcome to Volume 12, Issue #1 (31 Januray 2013) of Pharma Marketing News.
To usher in the New Year, it's traditional for pundits like Pharmaguy (aka John Mack, Publisher of Pharma Marketing News) to go out on a limb and make a few pharma industry predictions for the year. To compile his list, Pharmaguy used data from surveys, interviewed a pharmaceutical executive, and looked at the past year as an indication of what may be important in 2013 and beyond.
This article is a review of CMS's OpenPayments App for Physicians and Industry.
This article reviews data that supports one cause for the decrease in DTC spending not often mentioned: the shift to developing drugs for small populations of patients (so-called
Do pharma C-level executives really need to use social media directly or is it adequate that they see the value of social media within their organizations and ensure that others have the experience necessary to manage social media? This article attempts to answer that question with the help of Alexandra Fulford, an independent pharmaceutical industry strategy consultant who has worked with several pharmaceutical companies developing and running digital and social media training programs and workshops.
Although the pharmaceutical industry still contributes slightly over $1 billion to support healthcare professional continuing medical education (CME) via grants, advertising, and exhibits, total pharma support continues to decrease.